Skip to main content
C&R Research Inc. logo

C&R Research Inc. — Investor Relations & Filings

Ticker · 359090 ISIN · KR7359090008 KO Professional, scientific and technical activities
Open in API
Filings indexed 163 across all filing types
Latest filing 2021-08-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 359090

About C&R Research Inc.

https://www.cnrres.com/

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Recent filings

Filing Released Lang Actions
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for '엔에이치기업인수목적17호 주식회사' (NH SPAC 17). It covers the period from January 1, 2021, to June 30, 2021. It contains detailed company information, management discussion, and financial-related disclosures typical of a formal interim financial report filed with the Korean financial authorities (DART). According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim / Quarterly Report (IR). H1 2021
2021-08-12 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a merger decision (회사합병 결정) between NH Special Purpose Acquisition Company 17 and CNR Research. It details the merger ratio, valuation methods, impact on the company, and shareholder rights (such as appraisal rights). This type of filing is a formal announcement of a merger/takeover bid, which falls under the M&A Activity category.
2021-06-23 Korean
주권매매거래정지(SPAC 합병(예비심사청구대상))
Delisting Announcement Classification · 100% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to a SPAC merger process. It cites regulatory rules (KOSDAQ listing regulations) and provides specific dates and reasons for the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A (which would be a deal announcement) or share issues, it falls under the general regulatory filing category.
2021-06-23 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the shareholding changes of Samsung Securities in NH SPAC 17. This type of document is a mandatory regulatory disclosure regarding significant ownership thresholds and does not fit into categories like Annual Reports, Earnings Releases, or Proxy Statements. Therefore, it is classified as a Regulatory Filing (RNS).
2021-06-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in share ownership (specifically a decrease/increase in holdings) by a major shareholder (EBEST Investment & Securities) in a company (NH SPAC 17). This falls under the category of 'Major Shareholding Notification' (MRQ), as it tracks the crossing of ownership thresholds and changes in significant share ownership.
2021-06-07 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for NH Special Purpose Acquisition 17 Company (엔에이치기업인수목적17호 주식회사) covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, company overview, capital structure, and management details, which fits the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-13 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.